Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrentand Continuation Maintenance Veliparib (PARP inhibitor) in Subjects with Previously Untreated Stages III or IV High-Grade Serous EpithelialOvarian, Fallopian Tube, or Primary Peritoneal Cancer
IRB GOG3005
CC 15-866
Hospital Fairview, Hillcrest, Main Campus
Stage Stage 2, Stage 3, Stage 4
Phase Phase 3
Disease Fallopian Tube, Gynecologic, Ovarian, Peritoneal
